[October 07, 2016]

Global Central Nervous System Disorders Therapeutics Market Growth of 3.38% CAGR by 2020 - Analysis, Technologies & Forecasts Report 2016-2020 - Vendors: Pfizer, Sanofi, Zogenix - Research and Markets

Research and Markets has announced the addition of the "Global Central Nervous System Disorders Therapeutics Market 2016-2020" report to their offering.

The report forecasts the global central nervous system (CNS) disorders therapeutics market to grow at a CAGR of 3.38% during the period 2016-2020.

The report covers the present scenario and the growth prospects of the global central nervous system (CNS) disorders therapeutics market for 2016-2020.

To calculate the market size, the report considers the revenue generated from the sales of branded, generic, and off-labeled drugs used for the treatment of various CNS disorders including bipolar disorders, depression, epilepsy, PD, AD, Huntington's disease (HD), multiple sclerosis (MS), schizophrenia, attention-deficit hyperactivity disorder (ADHD), migraine, and anxiety.

Questions Answered:

• What will the market size be in 2020 and what will the growth rate be?
• What are the ey market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

• GlaxoSmithKline
• Pfizer
• Eli Lilly
• Abital Pharma
• Aprecia Pharmaceuticals
• Archer Pharmaceuticals
• MSI (News - Alert) Methylation Sciences
• Mylan
• Opexa
• Opko Health
• Par Pharmaceuticals
• SAGE Therapeutics
• Sanofi
• US WorldMeds
• Valeant Pharmaceuticals
• Zinfandel Pharmaceuticals
• Zogenix
  

Report Structure:

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Market research methodology

PART 04: Introduction

PART 05: Pipeline portfolio

PART 06: Market landscape

PART 07: Market segmentation by type of disease

PART 08: Geographical segmentation

PART 09: Market drivers

PART 10: Impact of drivers

PART 11: Market challenges

PART 12: Impact of drivers and challenges

PART 13: Market trends

PART 14: Vendor landscape

PART 15: Appendix

PART 16: About the Author

For more information about this report visit http://www.researchandmarkets.com/research/4vx2r6/global_central

View source version on businesswire.com: http://www.businesswire.com/news/home/20161007005609/en/

[ Back To TMCnet.com's Homepage ]